Gracell Biotechnologies (NASDAQ: GRCL)
Gracell Biotechnologies Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Gracell Biotechnologies Company Info
Gracell Biotechnologies, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing cell therapies to resolve industry challenges and fulfill unmet medical needs in the treatment of cancer. The company was founded by Wei Cao in May 2017 and is headquartered in Suzhou, China.
News & Analysis
Featured Article
Why Shares of Gracell Biotechnologies Are Rising Monday
The company said it is receiving financing of up to $150 million dollars from private investors.
Jim Halley | Aug 7, 2023
Featured Article
Why Shares of Gracell Biotechnologies Jumped Tuesday
Gracell climbed higher for a second consecutive day.
Jim Halley | Jun 13, 2023
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.